Product Overview
Hydroxypropyl-beta-cyclodextrin | T27563 | TargetMol Chemicals
CAS: 107745-73-3
Smiles: CC(O)COC[C@H]1OC2O[C@@H]3[C@@H](COCC(C)O)O[C@H](O[C@@H]4[C@@H](COCC(C)O)O[C@H](O[C@@H]5[C@@H](COCC(C)O)OC(O[C@@H]6[C@@H](COCC(C)O)O[C@H](O[C@@H]7[C@@H](COCC(C)O)OC(O[C@H]1[C@@H](O)[C@H]2O)[C@H](O)[C@@H]7O)[C@H](O)[C@@H]6O)[C@H](O)[C@@H]5O)[C@H](O)[C@@H]4O)[C@H](O)[C@@H]3O
Formula: C54H96O36
Pathway: N/A
Target: N/A
Receptor: N/A
Bioactivity: Hydroxypropyl-beta-cyclodextrin, also known as Hydroxypropyl-beta-cyclodextrin; THPB; HP-beta-CD; HPbCD; HP-beta-CyD; VTS-270; HPbetaCD; HPbetaCyD, is a drug candidate potentially for the treatment of Niemann-Pick type C diseases. In April 2009, hydroxypropyl-beta-cyclodextrin (HPbCD) was first approved.
Molecular Weight: 1321, 326
